LncRNA H19 acts as a ceRNA to promote glioblastoma malignancy by sponging miR-19b-3p and upregulating SERPINE1

Abstract Background Glioblastoma (GBM) is a highly aggressive brain tumor, characterized by genetic complexity and resistance to treatment. Despite significant advancements in cancer research, the mechanisms driving GBM progression remain poorly understood. This study investigates the molecular path...

Full description

Saved in:
Bibliographic Details
Main Authors: Wonyi Jang, Mijung Im, Goeun Yoon, Jungwook Roh, Wanyeon Kim
Format: Article
Language:English
Published: BMC 2025-06-01
Series:Cancer Cell International
Subjects:
Online Access:https://doi.org/10.1186/s12935-025-03868-x
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1850111459204268032
author Wonyi Jang
Mijung Im
Goeun Yoon
Jungwook Roh
Wanyeon Kim
author_facet Wonyi Jang
Mijung Im
Goeun Yoon
Jungwook Roh
Wanyeon Kim
author_sort Wonyi Jang
collection DOAJ
description Abstract Background Glioblastoma (GBM) is a highly aggressive brain tumor, characterized by genetic complexity and resistance to treatment. Despite significant advancements in cancer research, the mechanisms driving GBM progression remain poorly understood. This study investigates the molecular pathways associated with GBM, and focuses on long non-coding RNA H19 and its role in tumor growth and progression. Methods Analysis of Gene Expression Omnibus (GEO) dataset was performed to identify differentially expressed genes in GBM cells with H19 overexpression, revealing serpin family E member 1 (SERPINE1) as a potential target. Bioinformatics analyses were used to evaluate the differential expression of H19 and SERPINE1 in GBM tissues, perform survival analysis, and predict miR-19b-3p as a candidate miRNA. The expression levels of H19, miR-19b-3p, and SERPINE1 were validated using RT-qPCR and Western blotting. Dual-luciferase reporter assays were conducted to confirm the direct interactions between H19, miR-19b-3p, and SERPINE1. Cell viability and motility assays were performed to assess the effects of modulating H19/miR-19b-3p/SERPINE1 expression on cell survival, migration, and invasion. Results Bioinformatics analyses identified SERPINE1 as an oncogene upregulated in GBM cells with H19 overexpression, and the overexpression of H19 and SERPINE1 was linked to poor prognosis in GBM patients. Experimental validation demonstrated that H19 upregulates SERPINE1 expression, while miR-19b-3p directly binds to both H19 and SERPINE1, suppressing SERPINE1 expression. Functional assays further confirmed that H19 promotes cell survival, migration, and invasion, whereas miR-19b-3p inhibits these processes by downregulating SERPINE1. Conclusions These findings reveal a novel mechanism whereby H19 drives GBM progression by acting as a competing endogenous RNA (ceRNA) to sponge miR-19b-3p and upregulate SERPINE1 expression. Our results offer new insights into the regulatory interplay among H19, miR-19b-3p, and SERPINE1 in GBM cell lines, a relationship that has not been clearly defined in previous research. Moreover, the H19/miR-19b-3p/SERPINE1 axis highlights the potential use of H19, miR-19b-3p, and SERPINE1 as promising biomarkers and therapeutic targets in GBM.
format Article
id doaj-art-d1febe79081244cbae19c7f90dbd7c52
institution OA Journals
issn 1475-2867
language English
publishDate 2025-06-01
publisher BMC
record_format Article
series Cancer Cell International
spelling doaj-art-d1febe79081244cbae19c7f90dbd7c522025-08-20T02:37:36ZengBMCCancer Cell International1475-28672025-06-0125111610.1186/s12935-025-03868-xLncRNA H19 acts as a ceRNA to promote glioblastoma malignancy by sponging miR-19b-3p and upregulating SERPINE1Wonyi Jang0Mijung Im1Goeun Yoon2Jungwook Roh3Wanyeon Kim4Department of Science Education, Korea National University of EducationDepartment of Science Education, Korea National University of EducationDepartment of Science Education, Korea National University of EducationDepartment of Biology Education, Seowon UniversityDepartment of Science Education, Korea National University of EducationAbstract Background Glioblastoma (GBM) is a highly aggressive brain tumor, characterized by genetic complexity and resistance to treatment. Despite significant advancements in cancer research, the mechanisms driving GBM progression remain poorly understood. This study investigates the molecular pathways associated with GBM, and focuses on long non-coding RNA H19 and its role in tumor growth and progression. Methods Analysis of Gene Expression Omnibus (GEO) dataset was performed to identify differentially expressed genes in GBM cells with H19 overexpression, revealing serpin family E member 1 (SERPINE1) as a potential target. Bioinformatics analyses were used to evaluate the differential expression of H19 and SERPINE1 in GBM tissues, perform survival analysis, and predict miR-19b-3p as a candidate miRNA. The expression levels of H19, miR-19b-3p, and SERPINE1 were validated using RT-qPCR and Western blotting. Dual-luciferase reporter assays were conducted to confirm the direct interactions between H19, miR-19b-3p, and SERPINE1. Cell viability and motility assays were performed to assess the effects of modulating H19/miR-19b-3p/SERPINE1 expression on cell survival, migration, and invasion. Results Bioinformatics analyses identified SERPINE1 as an oncogene upregulated in GBM cells with H19 overexpression, and the overexpression of H19 and SERPINE1 was linked to poor prognosis in GBM patients. Experimental validation demonstrated that H19 upregulates SERPINE1 expression, while miR-19b-3p directly binds to both H19 and SERPINE1, suppressing SERPINE1 expression. Functional assays further confirmed that H19 promotes cell survival, migration, and invasion, whereas miR-19b-3p inhibits these processes by downregulating SERPINE1. Conclusions These findings reveal a novel mechanism whereby H19 drives GBM progression by acting as a competing endogenous RNA (ceRNA) to sponge miR-19b-3p and upregulate SERPINE1 expression. Our results offer new insights into the regulatory interplay among H19, miR-19b-3p, and SERPINE1 in GBM cell lines, a relationship that has not been clearly defined in previous research. Moreover, the H19/miR-19b-3p/SERPINE1 axis highlights the potential use of H19, miR-19b-3p, and SERPINE1 as promising biomarkers and therapeutic targets in GBM.https://doi.org/10.1186/s12935-025-03868-xGlioblastomaLncRNAH19miR-19b-3pSERPINE1CeRNA
spellingShingle Wonyi Jang
Mijung Im
Goeun Yoon
Jungwook Roh
Wanyeon Kim
LncRNA H19 acts as a ceRNA to promote glioblastoma malignancy by sponging miR-19b-3p and upregulating SERPINE1
Cancer Cell International
Glioblastoma
LncRNA
H19
miR-19b-3p
SERPINE1
CeRNA
title LncRNA H19 acts as a ceRNA to promote glioblastoma malignancy by sponging miR-19b-3p and upregulating SERPINE1
title_full LncRNA H19 acts as a ceRNA to promote glioblastoma malignancy by sponging miR-19b-3p and upregulating SERPINE1
title_fullStr LncRNA H19 acts as a ceRNA to promote glioblastoma malignancy by sponging miR-19b-3p and upregulating SERPINE1
title_full_unstemmed LncRNA H19 acts as a ceRNA to promote glioblastoma malignancy by sponging miR-19b-3p and upregulating SERPINE1
title_short LncRNA H19 acts as a ceRNA to promote glioblastoma malignancy by sponging miR-19b-3p and upregulating SERPINE1
title_sort lncrna h19 acts as a cerna to promote glioblastoma malignancy by sponging mir 19b 3p and upregulating serpine1
topic Glioblastoma
LncRNA
H19
miR-19b-3p
SERPINE1
CeRNA
url https://doi.org/10.1186/s12935-025-03868-x
work_keys_str_mv AT wonyijang lncrnah19actsasacernatopromoteglioblastomamalignancybyspongingmir19b3pandupregulatingserpine1
AT mijungim lncrnah19actsasacernatopromoteglioblastomamalignancybyspongingmir19b3pandupregulatingserpine1
AT goeunyoon lncrnah19actsasacernatopromoteglioblastomamalignancybyspongingmir19b3pandupregulatingserpine1
AT jungwookroh lncrnah19actsasacernatopromoteglioblastomamalignancybyspongingmir19b3pandupregulatingserpine1
AT wanyeonkim lncrnah19actsasacernatopromoteglioblastomamalignancybyspongingmir19b3pandupregulatingserpine1